Citation Impact
Citing Papers
Human Milk Composition
2012 Standout
Neurologic Complications of the Reactivation of Varicella–Zoster Virus
2000 Standout
The Normal and Pathological Physiology of Brain Water
1997
Recognition and Treatment of Shingles
1994
Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression
2006
Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine
2010 Standout
Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer
1988
Role of AID in Tumorigenesis
2007 StandoutNobel
Zona de l'enfant
1998 StandoutNobel
Combined interferon α2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial
2003
Cyclophilin inhibitors as antiviral agents
2013
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Medicinal plants: Traditions of yesterday and drugs of tomorrow
2005 Standout
HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia
2006 StandoutNobel
Treating hepatitis C
2005 StandoutNobel
Reverse Transcriptase and Corresponding Activity-Blocking Antibody for Monitoring SIV ℠ Infection in Macaques
1997
Serological responses in varicella and zoster assayed by immunoblotting
1988
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
1994
IMMUNE RESPONSES TO VARICELLA-ZOSTER VIRUS
1996
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Varicella zoster virus infection
2015
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
The AID Dilemma
2012 StandoutNobel
Ontogeny of water transport in rat brain: postnatal expression of the aquaporin‐4 water channel
1999 StandoutNobel
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Flash-Heat Inactivation of HIV-1 in Human Milk
2007
Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
2013
HIV Viral Load Monitoring in Resource‐Limited Regions: Optional or Necessary?
2006
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation
2005
Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks
2006 StandoutNobel
Mammalian deoxyribonucleoside kinases
1995
The role of IL-6 and STAT3 in inflammation and cancer
2005 Standout
Cyclosporin A Suppresses Replication of Hepatitis C Virus Genome in Cultured Hepatocytes
2003
Serum C‐Reactive Protein Concentration as an Indicator of Remission Status in Dogs with Multicentric Lymphoma
2007
Boron-Containing Nucleosides as Potential Delivery Agents for Neutron Capture Therapy of Brain Tumors
2004
Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro
2007
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Synthesis, Characterization, Cytotoxic Activities, and DNA-Binding Studies of Ternary Copper(II) Complexes with New Coumarin Derivatives
2010
Cytofluorometric assay for the determination of thymidine uptake and phosphorylation in living cells
1993
Acute phase response in animals: a review.
2009 Standout
Properties of human foamy virus relevant to its development as a vector for gene therapy
1999
Varicella and Herpes Zoster
1983
Identification of Predictors of Disease Status and Progression in Patients with Myeloma (MM)
2000
Antiviral drug discovery: broad-spectrum drugs from nature
2014
Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency
2005
Varicella-zoster virus
1996 Standout
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
1996 Standout
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.
1999
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
1999 Standout
Detection of HIV-1 P24 Gag in Plasma by a Nanoparticle-Based Bio-Barcode-Amplification Method
2008
HIV-1 Inhibitory Compounds from Calophyllum brasiliense Leaves
2004
Point-of-Care Diagnostics for Global Health
2008 Standout
High Levels of Viral Replication Contrast with Only Transient Changes in CD4+and CD8+Cell Numbers during the Early Phase of Experimental Infection with Simian Immunodeficiency Virus SIVmnd-1 inMandrillus sphinx
2002 StandoutNobel
Natural product and natural product derived drugs in clinical trials
2014 Standout
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
2008 Standout
The Chemistry of Neutron Capture Therapy
1998 Standout
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments]
1993
Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting
2005
Thyroid carcinoma
2003 Standout
International Staging System for Multiple Myeloma
2005 Standout
Works of J. Simon Gronowitz being referenced
Improved assays for DNA‐polymerizing enzymes by the use of enzymatically synthesized 5‐[125I]iodo‐2‘‐deoxyuridine triphosphate, illustrated by direct quantitation of anti‐HIV reverse transcriptase antibody and by serum DNA polymerase analyses.“
1990
A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity
1998
Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: Relation to RNA copy number and CD4 T-cell count
2005
Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma
2005
HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma
2003
Varicella Zoster Virus Deoxythymidine Kinase is Present in Serum before the Onset of Varicella
1989
Inhibition of herpes simplex virus production in vitro by Cyclosporin A
1992
The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma
1983
Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma
1985
A sensitive assay for the quantification of reverse transcriptase activity based on the use of carrier-bound template and non-radioactive-product detection, with special reference to human-immunodeficiency-virus isolation.
1996
Optimized assay for thymidine kinase and its application to the detection of antibodies against herpes simplex virus type 1- and 2-induced thymidine kinase
1980
Human serum antibodies to varicella-zoster virus thymidine kinase
1982
Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid
1983
Comparison of Two Human Immunodeficiency Virus (HIV) RNA Surrogate Assays to the Standard HIV RNA Assay
2005
Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia
1984
Application of an in vitro assay for serum thymidine kinase: Results on viral disease and malignancies in humans
1984
A Non-Radioactive Microtitre Plate Reverse Transcriptase (RT) Assay, Based on Immobilized Template, for Screening of RT Activity Inhibitors and Evaluation of their Mode of Action
1997
Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia
1987
Thymidine kinase in brain-tumor cysts
1985